Literature DB >> 11855540

Control of nocturnal gastric acidity: a role for low dose bedtime ranitidine to supplement daily omeprazole.

Malcolm Robinson1, Sheila Rodriguez-Stanley, Arthur A Ciociola, Jonathan Filinto, Sattar Zubaidi, Philip B Miner, Jerry D Gardner.   

Abstract

In some patients, proton pump inhibitors do not abolish nocturnal gastric acidity and additional evening antisecretory medication may be required. In 16 subjects with chronic heartburn, 24-hr gastric and esophageal pH were measured at baseline and again after six days of 20 mg omeprazole alone at 08:00 hr followed by placebo, 75 mg ranitidine, or 20 mg omeprazole at 22:00 hr. Integrated acidity was calculated from the cumulative, time-weighted mean acid concentrations (derived from pH values for each second). Baseline integrated gastric acidity increased progressively over 24 hr, whereas integrated esophageal acidity increased only until 22:00 hr. Morning omeprazole nearly abolished 24-hr esophageal acidity and significantly decreased overall gastric acidity but did not abolish nocturnal gastric acidity. Adding evening ranitidine or omeprazole nearly eliminated the nocturnal increase in gastric acidity. Integrated acidity was more sensitive than time pH < 4 in assessing gastric and esophageal acidity as well as their inhibition by omeprazole and ranitidine. In conclusion, integrated acidity provides novel information regarding the synergy of omeprazole plus ranitidine. Adding low-dose ranitidine helps control nocturnal gastric acidity that can occur with conventional omeprazole administration. Although the heartburn patients in the present study had nocturnal gastric acidity without accompanying nocturnal esophageal acid reflux, other patients who do have nocturnal esophageal reflux might profit from addition of bedtime ranitidine or another gastric antisecretory agent.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11855540     DOI: 10.1023/a:1013749501241

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  24 in total

1.  THE DETERMINATION OF GASTRIC ACIDITY BY THE GLASS ELECTRODE.

Authors:  E W MOORE; R W SCARLATA
Journal:  Gastroenterology       Date:  1965-08       Impact factor: 22.682

2.  24-h pH monitoring for gastroesophageal reflux disease: already standard but not yet gold?

Authors:  E M Quigley
Journal:  Am J Gastroenterol       Date:  1992-09       Impact factor: 10.864

3.  Integrated acidity and the pathophysiology of gastroesophageal reflux disease.

Authors:  J D Gardner; S Rodriguez-Stanley; M Robinson
Journal:  Am J Gastroenterol       Date:  2001-05       Impact factor: 10.864

4.  Inhibition of intragastric acidity in healthy subjects dosed with ranitidine 75 mg: a comparative study with cimetidine and placebo.

Authors:  C E Grimley; S Constantinides; C C Snell; J G Mills; C U Nwokolo
Journal:  Aliment Pharmacol Ther       Date:  1997-10       Impact factor: 8.171

5.  Nocturnal recovery of gastric acid secretion with twice-daily dosing of proton pump inhibitors.

Authors:  P L Peghini; P O Katz; N A Bracy; D O Castell
Journal:  Am J Gastroenterol       Date:  1998-05       Impact factor: 10.864

6.  Gastric acid hypersecretion in refractory gastroesophageal reflux disease.

Authors:  M J Collen; J H Lewis; S B Benjamin
Journal:  Gastroenterology       Date:  1990-03       Impact factor: 22.682

7.  Gastric acid secretion rate and buffer content of the stomach after eating. Results in normal subjects and in patients with duodenal ulcer.

Authors:  J S Fordtran; J H Walsh
Journal:  J Clin Invest       Date:  1973-03       Impact factor: 14.808

8.  Gastro-oesophageal reflux associated with nocturnal gastric acid breakthrough on proton pump inhibitors.

Authors:  P O Katz; C Anderson; R Khoury; D O Castell
Journal:  Aliment Pharmacol Ther       Date:  1998-12       Impact factor: 8.171

9.  Appropriate acid suppression for the management of gastro-oesophageal reflux disease.

Authors:  N J Bell; D Burget; C W Howden; J Wilkinson; R H Hunt
Journal:  Digestion       Date:  1992       Impact factor: 3.216

10.  Gastric acid and pepsin secretion in patients with Barrett's esophagus and appropriate controls.

Authors:  B I Hirschowitz
Journal:  Dig Dis Sci       Date:  1996-07       Impact factor: 3.199

View more
  3 in total

1.  Gastroesophageal reflux disease and sleep disorders: evidence for a causal link and therapeutic implications.

Authors:  Hye-Kyung Jung; Rok Seon Choung; Nicholas J Talley
Journal:  J Neurogastroenterol Motil       Date:  2010-01-31       Impact factor: 4.924

Review 2.  Medical management of nocturnal symptoms of gastro-oesophageal reflux disease in the elderly.

Authors:  Samer Gawrieh; Reza Shaker
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

3.  Comparison of gastroesophageal reflux disease symptoms and proton pump inhibitor response using gastroesophageal reflux disease impact scale questionnaire.

Authors:  So Young Jo; Nayoung Kim; Ji Hwan Lim; Cheol Min Shin; Young Soo Park; Dong Ho Lee; Hyun Chae Jung
Journal:  J Neurogastroenterol Motil       Date:  2013-01-08       Impact factor: 4.924

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.